Access cutting-edge inflammatory bowel disease (ibd) treatment through this clinical trial at a research site in Wilmington. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Wilmington location
Preparing your pre-screening questions…
Access inflammatory bowel disease (ibd) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related inflammatory bowel disease (ibd) treatment provided free
Check if you qualify for this inflammatory bowel disease (ibd) clinical trial in Wilmington, NC
No-Cost Study Care
Local to Wilmington
Convenient for NC residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Data collected through the registry may be used to address a range of research questions and objectives, including but not limited to the following: Research question: Is there an increased risk of adverse maternal, fetal, or infant outcomes among individuals who are exposed to Inflammatory Bowel Disease (IBD) treatments during pregnancy? The primary objective of the registry is to estimate the prevalence of major congenital malformations among pregnant individuals with IBD who are exposed to an IBD pharmacotherapy during pregnancy. The secondary objectives of the registry are: To estimate the prevalence of other maternal, fetal, and infant outcomes among pregnant individuals with IBD who are exposed to IBD pharmacotherapies during pregnancy. To contextualize the prevalence of outcomes among pregnant individuals who are exposed to IBD pharmacotherapies during pregnancy and estimate the prevalence of all outcomes of interest among pregnant individuals with IBD who are not exposed to any IBD pharmacotherapies or an IBD pharmacotherapy of interest during pregnancy. If sample size permits, to estimate the risk ratio for each outcome, comparing the outcomes of pregnant individuals with IBD who are exposed to IBD pharmacotherapy with those who are not exposed to any IBD pharmacotherapies or an IBD pharmacotherapy of interest during pregnancy. Data collection may be used to determine pharmacotherapy-specific use with or without unexposed cohorts on an as-needed basis, as sample size allows.
Sponsor: CorEvitas
Yes, this clinical trial (NCT06910553) has an active research site in Wilmington, NC that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for inflammatory bowel disease (ibd) treatment options in Wilmington, NC, this clinical trial (NCT06910553) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Wilmington research site is actively enrolling participants for this clinical trial. You'll receive care from experienced inflammatory bowel disease (ibd) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all inflammatory bowel disease (ibd) clinical trials near you to find additional studies recruiting in your area.
See all multiple myeloma clinical trials recruiting in Wilmington — not just this study.
Browse Multiple Myeloma Trials in Wilmington →